UTSW Clinical Research Site for Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)

UTSW 神经科学临床试验卓越网络临床研究网站 (NeuroNEXT)

• 批准号: 10201768
• 负责人: RICHARD B DEWEY
• 金额: $ 32.4万
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-07-15 至 2023-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10201768
• 关键词: Adult; African American; Area; Brain; Caring; Catchment Area; Center for Translational Science Activities; Child; Clinical; Clinical Research; Clinical Trials; Clinical and Translational Science Awards; Clinics and Hospitals; Collaborations; Communities; Community Outreach; Databases; Development; Disease; Educational Curriculum; Enrollment; Ensure; Equipment; Expenditure; Faculty; Funding; Future; Goals; Health; Health Resources; Health system; Hispanic Americans; Hospitals; Human Resources; Institutes; Institution; Integrated Health Care Systems; Leadership; Medical center; Mentorship; Nervous system structure; Neurology; Neurosciences; Neurosciences Research; Patient Recruitments; Patients; Pediatric Hospitals; Pediatric Neurology; Pediatrics; Performance; Population; Population Heterogeneity; Process; Psychiatry; Publications; Rehabilitation therapy; Research; Research Infrastructure; Research Personnel; Research Support; Research Training; Resources; Services; Site; Speed; Structure; Talents; Texas; Time; Training; Training Programs; Training Support; Translating; United States; United States National Institutes of Health; Universities; University Hospitals; academic program; career development; clinical data repository; clinical research site; clinical trial enrollment; collaborative environment; data quality; data warehouse; expectation; experience; improved; innovation; medical specialties; member; metropolitan; multi-ethnic; multidisciplinary; nervous system disorder; neurosurgery; operation; participant enrollment; professor; programs; recruit; screening; success; tool; translational medicine; translational neuroscience

This is an application for competitive renewal of UT Southwestern Medical Center (UTSW) as a clinical research site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT). The project continues to be led by Drs. Mark Goldberg and Susan Iannaccone, who bring experience in program leadership with complementary areas of expertise in adult and pediatric neurology, respectively. The project has demonstrated enrollment and operational successes in the initial funding period. UTSW is one of the few sites selected to participate in all eight funded studies by the network (NN109 site selection is still underway). We are among the top five enrolling sites and have met or exceeded network averages for patient recruitment, retention, timeliness, data quality and accuracy metrics. We propose to expand on these successes in the next cycle. First, we will take advantage of new institutional relationships to expand the number of patients available for screening and enrollment. UTSW has partnered with a large health network, Texas Health Resources, to create an integrated health system of 31 hospitals and clinics called the Southwestern Health Resources (SWHR). Altogether, our collaborative research relationships with community care partners and health systems brings potential enrollment access to almost three quarters of the Dallas-Fort Worth metroplex. In addition, the newly formed Peter O’Donnell Jr. Brain Institute at UTSW brings together several departments and centers focused on the study of the nervous system under a multi-disciplinary, collaborative umbrella. Second, we will make use of innovative research resources to improve the speed, efficiency, and quality of clinical trials. With the initial launch of NeuroNEXT, we established the Neuroscience Translational Research Center (NTRC), which provides core services, dedicated research space, equipment, regulatory expertise, and trained personnel for NIH and other studies across the clinical neurosciences. This resource has grown in scope and quality, and will be further enhanced with improved database support, an expanded institutional EMR-to-research data warehouse, and new online tools for patient recruitment and enrolment. Third, we will implement a clinical research curriculum, taking advantage of existing resources for early stage investigators (ESI) in collaboration with the Center for Translational Medicine (CTM) at UTSW. We have had ESIs serve as study PIs on six of the eight NeuroNEXT studies, proving our commitment to early career development. We will continue provide structured curriculum with clinical research mentorship to several candidates from our talented pool of ESIs.

这是UT西南医学中心（UTSW）作为神经科学临床试验卓越网络（NeuroNEXT）临床研究中心的竞争性更新申请。该项目继续由Mark Goldberg和Susan Iannaccone博士领导，他们分别在成人和儿科神经病学领域的专业知识互补领域带来了项目领导经验。该项目在最初的供资期内已经证明了招生和运作的成功。UTSW是少数几个被选中参与网络资助的所有八项研究的研究中心之一（NN 109研究中心的选择仍在进行中）。我们是排名前五的注册网站之一，在患者招募、保留、及时性、数据质量和准确性指标方面达到或超过了网络平均水平。我们提议在下一个周期扩大这些成功。首先，我们将利用新的机构关系，扩大可用于筛选和入组的患者数量。UTSW与一个大型健康网络Texas Health Resources合作，创建了一个由31家医院和诊所组成的综合健康系统，称为西南健康资源（SWHR）。总而言之，我们与社区护理合作伙伴和卫生系统的合作研究关系为达拉斯-沃斯堡大都市的近四分之三带来了潜在的入学机会。此外，新成立的小彼得奥唐纳。UTSW的脑研究所汇集了多个部门和中心，专注于多学科协作伞下的神经系统研究。二是利用创新研究资源，提高临床试验速度、效率和质量。随着NeuroNEXT的首次推出，我们建立了神经科学转化研究中心（NTRC），为NIH和其他临床神经科学研究提供核心服务，专用研究空间，设备，监管专业知识和训练有素的人员。这一资源的范围和质量都有所提高，并将通过改进数据库支持、扩大机构EMR到研究数据仓库以及用于患者招募和登记的新在线工具得到进一步加强。第三，我们将实施一个临床研究课程，利用现有的早期研究者（ESI）的资源，与UTSW的转化医学中心（CTM）合作。我们已经让ESI担任了八项NeuroNEXT研究中的六项研究PI，证明了我们对早期职业发展的承诺。我们将继续提供结构化的课程与临床研究导师从我们的人才库的ESI几个候选人。